Intra-Cellular Therapies Inc (NAS:ITCI)
$ 69.465 -1.545 (-2.18%) Market Cap: 7.33 Bil Enterprise Value: 6.98 Bil PE Ratio: 0 PB Ratio: 11.31 GF Score: 57/100

Intra-Cellular Therapies Inc (ITCI) Stock Estimates Data

Intra-Cellular Therapies Inc (ITCI) 12 Month Price Targets

Intra-Cellular Therapies Inc (ITCI) Analyst Rating